MedPath

Evaluation of aspirin and Omega 3-6-9 in the amount of the uterine 's blood flow

Phase 2
Conditions
Recurrent miscarriage.
Spontaneous abortion
Registration Number
IRCT201103253014N3
Lead Sponsor
Mazandaran University of Medical Sciences, Vice chancellor for research
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
45
Inclusion Criteria

Inclusion:
Women that have one or more recurrent miscarriage with no reason in their first three mister.
, Exclusion:
Having no hormone therapy;Having no chronic disease in their first three mister

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
terus‘s blood flow. Timepoint: every 2 month. Method of measurement: dapler sonography.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath